Displaying drugs 901 - 925 of 2785 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Calfactant | Not Available |  | A lung surfactant for the prophylaxis of respiratory distress syndrome in high-risk infants. | Pulmonary Surfactants / Surface-Active Agents |
| Abarelix | 1416.09 C72H95ClN14O14 |  | For palliative treatment of advanced prostate cancer. | Hormone Antagonists |
| Plicamycin | 1085.1454 C52H76O24 |  | For the treatment of testicular cancer, as well as hypercalcemia and hypercalciuria associated with a variety of advanced forms of cancer. | Antineoplastic Agents |
| Sitaxentan | 454.905 C18H15ClN2O6S2 |  | Investigated for use/treatment in pulmonary hypertension, connective tissue diseases, hypertension, and congestive heart failure. | Antihypertensives for Pulmonary Arterial Hypertension |
| Fluspirilene | 475.5727 C29H31F2N3O |  | An antipsychotic agent used in the treatment of schizophrenia. | Diphenylbutylpiperidine Derivatives |
| Zilucoplan | 3562.229 C172H278N24O55 |  | A complement inhibitor used to treat generalized myasthenia gravis in anti-acetylcholine receptor (AChR) antibody-positive adults. | Amino Acids, Peptides, and Proteins / Antineoplastic and Immunomodulating Agents / Blood Proteins / Complement Inactivating Agents / Immunoproteins / Immunosuppressive Agents / Peptides / Proteins |
| Gefitinib | 446.902 C22H24ClFN4O3 |  | A tyrosine kinase inhibitor used as first-line therapy to treat non-small cell lung carcinoma (NSCLC) that meets certain genetic mutation criteria. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Sodium lauryl sulfoacetate | 330.41 C14H27NaO5S |  | A laxative indicated in the treatment of constipation and bowel preparation for rectal endoscopy. | Enemas |
| Phloxine B | 829.63 C20H2Br4Cl4Na2O5 |  | For use in dental disclosing products, allowing for highlighting of bacterial placques. | Fluoresceins / Fluorescent Dyes |
| Mobocertinib | 585.709 C32H39N7O4 |  | An oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Tyrosine Kinase Inhibitors |
| 1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) | 749.02 C40H77O10P |  | A synthetic lung surfactant used to treat infant respiratory distress syndrome. | Not Available |
| Albuterol | 239.3107 C13H21NO3 |  | A beta-2 adrenergic receptor agonist used to treat asthma, bronchitis, COPD, as well as prevent exercise induced bronchospasms. | Agents producing tachycardia / Agents that produce hypertension |
| Testosterone enantate benzilic acid hydrazone | 624.866 C40H52N2O4 |  | Not Annotated | Androstanes / Androstenes / Androstenols / Fused-Ring Compounds / Gonadal Hormones / Gonadal Steroid Hormones / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / Steroids / Testosterone and derivatives / Testosterone Congeners |
| DL-dimyristoylphosphatidylcholine | 677.945 C36H72NO8P |  | DL-dimyristoylphosphatidylcholine is not an active pharmaceutical agent and has no indication. | Indicators and Reagents / Phosphatidylcholines |
| Tiotropium | 392.512 C19H22NO4S2 |  | A long-acting bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). | Agents producing tachycardia |
| Ambroxol | 378.108 C13H18Br2N2O |  | A medication indicated for airway secretion clearance therapy. | Anesthetics, Local / Expectorants / Selective Beta 2-adrenergic Agonists |
| Luliconazole | 354.27 C14H9Cl2N3S2 |  | A topical antifungal agent used to treat fungal infections. | Imidazole and Triazole Derivatives |
| Pretomanid | 359.2574 C14H12F3N3O5 |  | Part of a three-drug regimen used for the treatment of extensively drug-resistant and multidrug-resistant pulmonary tuberculosis. | Drugs for Treatment of Tuberculosis |
| Bemotrizinol | 627.826 C38H49N3O5 |  | An ingredient used in sunscreen to block UVA and UVB radiation. | Sunscreen Agents |
| Sinecatechins | Not Available |  | A topical agent used to treat external genital and perianal warts in immunocompetent adult patients. | Antiviral Agents |
| Boscalid | 343.207 C18H12Cl2N2O |  | Boscalid has been investigated for the treatment of OSDI, Glaucoma, Staining, Schirmers, and Disease Severity, among others. | Benzene Derivatives / Nicotinic Acids / Pyridines |
| Olutasidenib | 354.79 C18H15ClN4O2 |  | An isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation as detected by an FDA-approved test. | Antineoplastic Agents / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inducers / Cytochrome P-450 CYP1A2 Inducers (strength unknown) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / Enzyme Inhibitors / Heterocyclic Compounds, Fused-Ring / Isocitrate dehydrogenase-1 (IDH1) inhibitors / Isocitrate Dehydrogenase-1 Inhibitors / MATE 1 Inhibitors / MATE 2 Inhibitors / MATE inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / OCT2 Inhibitors / P-glycoprotein inhibitors / Potential QTc-Prolonging Agents / QTc Prolonging Agents |
| Delafloxacin | 440.76 C18H12ClF3N4O4 |  | A fluoroquinolone antibiotic used to treat skin and skin structure infections. | Fluoroquinolones |
| Danicopan | 580.418 C26H23BrFN7O3 |  | A small molecule complement factor D inhibitor used to treat extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria. | Amines / Amino Acids / Amino Acids, Cyclic / Amino Acids, Peptides, and Proteins / Antineoplastic and Immunomodulating Agents / BCRP/ABCG2 Inhibitors / Complement Inactivating Agents / Heterocyclic Compounds, Fused-Ring / Imino Acids / Immunosuppressive Agents / P-glycoprotein inhibitors / Pyrazoles / Pyridines |
| Gallium Ga-68 gozetotide | 1011.909 C44H59GaN6O17 |  | A radiopharmaceutical agent used in the diagnosis of prostate-specific membrane antigen (PSMA) positive lesions in male patients during positron emission tomography. | Gallium Radioisotopes / Radioactive Diagnostic Agent / Radiopharmaceuticals |
Displaying drugs 901 - 925 of 2785 in total